Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Mason

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Regenerative Medicine|September 28, 2010
Defeating stem cell tourism. ForewordChris Mason, Elisa Manzotti
Regenerative Medicine|November 12, 2009
Regen: the industry responsible for cell-based therapiesChris Mason, Elisa Manzotti
Regenerative Medicine|November 12, 2009
Assessing the value of autologous and allogeneic cells for regenerative medicineChris Mason, Peter Dunnill
Regenerative Medicine|May 1, 2007
Regenerative medicine bioprocessing: the need to learn from the experience of other fieldsChris Mason, Mike Hoare
Regenerative Medicine|March 10, 2010
The Translation Cycle: round and round in cycles is the only way forward for regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|December 25, 2008
New era dawns for US stem cell researchChris Mason, Elisa Manzotti
Regenerative Medicine|September 19, 2009
Bioaesthetics and regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|May 15, 2009
Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycleChris Mason, Elisa Manzotti
Regenerative Medicine|July 8, 2009
'The Little Purple Book': BSI glossary of regenerative medicine. ForewordChris Mason, Elisa Manzotti
Regenerative Medicine|December 25, 2007
A brief definition of regenerative medicineChris Mason, Peter Dunnill
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Regenerative Medicine|September 28, 2010
Defeating stem cell tourism. ForewordChris Mason, Elisa Manzotti
Regenerative Medicine|November 12, 2009
Regen: the industry responsible for cell-based therapiesChris Mason, Elisa Manzotti
Regenerative Medicine|November 12, 2009
Assessing the value of autologous and allogeneic cells for regenerative medicineChris Mason, Peter Dunnill
Regenerative Medicine|May 1, 2007
Regenerative medicine bioprocessing: the need to learn from the experience of other fieldsChris Mason, Mike Hoare
Regenerative Medicine|March 10, 2010
The Translation Cycle: round and round in cycles is the only way forward for regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|December 25, 2008
New era dawns for US stem cell researchChris Mason, Elisa Manzotti
Regenerative Medicine|September 19, 2009
Bioaesthetics and regenerative medicineChris Mason, Elisa Manzotti
Regenerative Medicine|May 15, 2009
Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycleChris Mason, Elisa Manzotti
Regenerative Medicine|July 8, 2009
'The Little Purple Book': BSI glossary of regenerative medicine. ForewordChris Mason, Elisa Manzotti
Regenerative Medicine|December 25, 2007
A brief definition of regenerative medicineChris Mason, Peter Dunnill
Pageof 11